| Original language | English |
|---|---|
| Pages (from-to) | 198-208 |
| Journal | European Journal of Haematology |
| Volume | 96 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2016 |
Cite this
}
A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model. / Blommestein, Hedwig M.; Verelst, Silvia G. R.; de Groot, Saskia; Huijgens, Peter C.; Sonneveld, Pieter; Uyl-de Groot, Carin A.
In: European Journal of Haematology, Vol. 96, No. 2, 02.2016, p. 198-208.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model
AU - Blommestein, Hedwig M.
AU - Verelst, Silvia G. R.
AU - de Groot, Saskia
AU - Huijgens, Peter C.
AU - Sonneveld, Pieter
AU - Uyl-de Groot, Carin A.
PY - 2016/2
Y1 - 2016/2
KW - multiple myeloma
KW - cost-effectiveness analysis
KW - real-world data
KW - registries
KW - thalidomide
KW - bortezomib
KW - lenalidomide
U2 - 10.1111/ejh.12571
DO - 10.1111/ejh.12571
M3 - Article
VL - 96
SP - 198
EP - 208
JO - European Journal of Haematology
JF - European Journal of Haematology
SN - 0902-4441
IS - 2
ER -